The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Anthony Lebiedzinski - Sidoti & Company - Analyst
: Yes, good morning, everyone, and thanks for taking the questions. So first, China and South Korea, they post the net sales and active customer
account increases on a sequential basis, you guys talked about. Incentive offerings, helping those out at the start of the year.
So, just curious as to what your plans are for additional incentives, in these countries and elsewhere, how do you guys think about that as far as
that's concerned? I'd love to hear your thoughts on that.
Question: Anthony Lebiedzinski - Sidoti & Company - Analyst
: Good morning.
Question: Anthony Lebiedzinski - Sidoti & Company - Analyst
: That's encouraging to hear. Yeah, thanks for that. And then, with respect to the higher -- so you talked about the seasonality of the business, which
is understandable, as far as the new product launches that are planned for this year, can you share some more specifics about the timing and kind
of what's embedded in your guidance?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
APRIL 23, 2025 / 3:00PM, USNA.N - Q1 2025 USANA Health Sciences Inc Earnings Call
Question: Anthony Lebiedzinski - Sidoti & Company - Analyst
: Thanks, Doug. And then, so now that you've had a higher for four months, do you guys have any updated thoughts on the synergy opportunities?
Question: Anthony Lebiedzinski - Sidoti & Company - Analyst
: Got it. Yeah, that makes sense. And can you give us any update on India, how that's progressing?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
APRIL 23, 2025 / 3:00PM, USNA.N - Q1 2025 USANA Health Sciences Inc Earnings Call
Question: Anthony Lebiedzinski - Sidoti & Company - Analyst
: Got it. right, that's thanks, Brent. Then lastly for me, as far as the potential tariff impact, so I know you guys brought in some additional inventories
to try to get ahead of that. So do you think what you have done so far, like, is this for one quarter out as far as the higher inventory or is it you know
more than that?
I mean, you just trying to, obviously it's still. Very fluid and dynamic environment as it relates to tariffs. But just maybe if you could expand on that
as far as like the level of inventory that you have for raw materials, is it good like for how long of a period of time should that be good for?
Question: Anthony Lebiedzinski - Sidoti & Company - Analyst
: That makes a lot of sense. Well, thank you very much, guys, and best of luck.
Question: Ivan Feinseth - Tigress Financial Partners - Analyst
: Congratulations on the great start to the year and the success with the higher acquisition. And my question, so, just starting with China, what have
been some of the new products that were launched there and the reception that you're getting and what do you see as some of the new categories
that you're going to be launching?
Question: Ivan Feinseth - Tigress Financial Partners - Analyst
: Okay. And then for my big question is, that there are a lot of competing products on the market that contain a lot of bad ingredients, and now
what do you think your opportunity is as [RFK] starts to implement the elimination of a lot of these colors, dyes, artificial ingredients, and you tend
to lean toward a more natural product. How do you feel that the opportunity, how do you feel that will create an opportunity for you?
Question: Ivan Feinseth - Tigress Financial Partners - Analyst
: Thank you. Congratulations again and wish you a great year.
|
